| Cat. No. |
Product Name |
Information |
| PC-72902 |
LY 3372689
O-GlcNAcase inhibitor
|
LY 3372689 is an oral, small molecule O-GlcNAcase (OGA) enzyme inhibitor for the treatment of Alzeimer's disease. |
| PC-72901 |
LP0200
IL17 modulator
|
LP0200 (LP 0200) is a small-molecule modulator of IL-17 under development for psoriasis. |
| PC-72887 |
FECH inhibitor 4e
Ferrochelatase inhibitor
|
FECH inhibitor 4e (FECH-IN-4e) is a potent, specifc, competitive inhibitor of ferrochelatase (FECH) with IC50 in the high-nanomolar range. |
| PC-72885 |
LCS3
GSR inhibitor
|
LCS3 is a small molecule that selectively impairs the growth of human lung adenocarcinoma (LUAD) cells, induces oxidative stress, inhibits glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50 of 3.3 and 3.8 uM, respectively. |
| PC-72877 |
CW5107
HSD17B7 inhibitor
|
CW5107 (CW 5107) is a small molecule HSD17B7 inhibitor that enhances oligodendrocyte formation. |
| PC-72876 |
CW4142
SC4MOL inhibitor
|
CW4142 (CW 4142) is a small molecule SC4MOL inhibitor that enhances oligodendrocyte formation. |
| PC-72871 |
NERx 329
RPA inhibitor
|
NERx 329 (RPAi 329, NERx329) is a novel potent, specific inhibitor of replication protein A (RPA), demonstrated potent RPA inhibitory activity in vitro, in vivo, and in cellular assays. |
| PC-72865 |
MN132.0262
APOBEC3G inhibitor
|
MN132.0262 is a small molecule, dual inhibitor of A3G (APOBEC3G, IC50=20 uM). |
| PC-72864 |
MN256.0102
APOBEC3G inhibitor
|
MN256.0102 is a small-molecule APOBEC3G DNA cytosine deaminase inhibitor with IC50 of 3.9 uM. |
| PC-72863 |
MN256.0105
APOBEC3G inhibitor
|
MN256.0105 is a small-molecule APOBEC3G DNA cytosine deaminase inhibitor with IC50 of 4.3 uM. |
| PC-72855 |
Pixatimod
Heparanase inhibitor
|
Pixatimod (PG545) is a heparan sulfate (HS) mimetic and anticancer agent and a potent inhibitor of heparanase. |
| PC-72846 |
Simufilam hydrochloride
Filamin A corrector
|
Simufilam hydrocloride (PTI-125) is a small molecule targeting scaffolding protein filamin A (FLNA), preferentially binds altered FLNA and restores its native conformation. |
